Contingency Management for Attendance - 2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00249639
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : January 12, 2017
UConn Health
Information provided by:
National Institute on Drug Abuse (NIDA)

Brief Summary:
The purpose of this study is to evaluate the effectiveness of a low-cost contingency management procedure as compared to standard treatment. Using a cross-over design, CM is implemented at different community-based clinics and compared with non-CM in the same facilities. Research staff collects information regarding patients' demographic characteristics, attendance, and outcomes at the clinics. During Phase A (non-CM), standard clinical practice is in place. During Phase B (CM), all patients have the chance to win prizes by coming to treatment. Each participating clinic is randomly assigned to receive either the A or B phase first; each phase is in effect for 16 weeks.

Condition or disease Intervention/treatment Phase
Substance Abuse Behavioral: Contingency management Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 300 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Contingency Management for Attendance
Study Start Date : January 2004
Actual Primary Completion Date : January 2006
Actual Study Completion Date : January 2006

Intervention Details:
    Behavioral: Contingency management
    Rewards valued $1-$100

Primary Outcome Measures :
  1. Drug use [ Time Frame: baseline and each follow-up ]
  2. Retention [ Time Frame: baseline and each follow-up ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Subjects will be patients in treatment at one of the participating clinics during the study period. There are no other inclusion or exclusion criteria because we wish to make enrollment open to increase generalizability.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00249639

United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
UConn Health
Principal Investigator: Nancy Petry, Ph.D. UConn Health

Responsible Party: Nancy Petry, Ph.D., UConn Health Center Identifier: NCT00249639     History of Changes
Other Study ID Numbers: NIDA-16855-2
First Posted: November 7, 2005    Key Record Dates
Last Update Posted: January 12, 2017
Last Verified: May 2008

Keywords provided by National Institute on Drug Abuse (NIDA):
Contingency Management
Substance Abuse Treatment

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders